Letter to the Editor: The Use of Rifampin in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Comparative Studies
-
Published:2024-03
Issue:3
Volume:39
Page:e15
-
ISSN:0883-5403
-
Container-title:The Journal of Arthroplasty
-
language:en
-
Short-container-title:The Journal of Arthroplasty
Reference5 articles.
1. The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies;Kruse;J Arthroplasty,2022
2. Rifampin, Rifapentine, and Rifabutin are active against intracellular periprosthetic joint infection-associated Staphylococcus epidermidis;Fisher;Antimicrob Agents Chemother,2021
3. The impact of surgical strategy and rifampin on treatment outcome in cutibacterium periprosthetic joint infections;Kusejko;Clin Infect Dis,2021
4. If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study;Beldman;Clin Infect Dis,2021
5. Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations;Fiaux;BMC Infect Dis,2016